📊 SRTS Key Takeaways
Is Sensus Healthcare, Inc. (SRTS) a Good Investment?
Sensus Healthcare is burning cash at an unsustainable rate with stagnant revenue growth (0% YoY), deteriorating profitability (-$2.6M net income, -216% YoY), and severe operating losses (-$4.4M on $3.4M revenue). While the strong cash position ($18.3M) provides a ~4-5 year runway, the company is destroying shareholder value with no clear path to profitability or operational cash flow sustainability.
Sensus Healthcare, Inc. Key Strengths (SRTS)
- Strong cash position of $18.3M with zero debt burden (Debt/Equity 0.0x)
- Excellent liquidity ratios (Current Ratio 7.27x, Quick Ratio 4.45x) provide financial flexibility
- Gross margin of 29.2% suggests underlying product viability at manufacturing level
SRTS Stock Risks: Sensus Healthcare, Inc. Investment Risks
- Severe and worsening profitability: -$2.6M net income with -216% YoY deterioration and -128.4% operating margin
- Negative operating cash flow of -$3.8M indicates core business is burning cash unsustainably
- Revenue stagnation at 0% YoY growth with massive operating expense structure relative to sales
- Large gap between gross margin (29.2%) and operating margin (-128.4%) reveals inefficient cost structure or commercialization challenges
- At current $3.8M annual burn rate, cash runway limited to 4-5 years without operational improvement
Key Metrics to Watch
- Operating cash flow trajectory and return to positive cash generation from operations
- Revenue growth acceleration and customer acquisition metrics
- Operating expense reduction to achieve positive operating income
- Cash runway sustainability and quarterly cash burn rate
Sensus Healthcare, Inc. (SRTS) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 7.27x current ratio provides a solid financial cushion.
SRTS Profit Margin, ROE & Profitability Analysis
SRTS vs Healthcare Sector: How Sensus Healthcare, Inc. Compares
How Sensus Healthcare, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Sensus Healthcare, Inc. Stock Overvalued? SRTS Valuation Analysis 2026
Based on fundamental analysis, Sensus Healthcare, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Sensus Healthcare, Inc. Balance Sheet: SRTS Debt, Cash & Liquidity
SRTS Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Sensus Healthcare, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $0.41 reflects profitable operations.
SRTS Revenue Growth, EPS Growth & YoY Performance
SRTS Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $6.9M | -$943.0K | $-0.06 |
| Q2 2025 | $7.3M | -$1.0M | $-0.06 |
| Q1 2025 | $8.3M | $2.3M | $0.14 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Sensus Healthcare, Inc. Dividends, Buybacks & Capital Allocation
SRTS SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Sensus Healthcare, Inc. (CIK: 0001494891)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SRTS
What is the AI rating for SRTS?
Sensus Healthcare, Inc. (SRTS) has an AI grade of D with 88% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SRTS's key strengths?
Claude: Strong cash position of $18.3M with zero debt burden (Debt/Equity 0.0x). Excellent liquidity ratios (Current Ratio 7.27x, Quick Ratio 4.45x) provide financial flexibility.
What are the risks of investing in SRTS?
Claude: Severe and worsening profitability: -$2.6M net income with -216% YoY deterioration and -128.4% operating margin. Negative operating cash flow of -$3.8M indicates core business is burning cash unsustainably.
What is SRTS's revenue and growth?
Sensus Healthcare, Inc. reported revenue of $3.4M.
Does SRTS pay dividends?
Sensus Healthcare, Inc. does not currently pay dividends.
Where can I find SRTS SEC filings?
Official SEC filings for Sensus Healthcare, Inc. (CIK: 0001494891) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SRTS's EPS?
Sensus Healthcare, Inc. has a diluted EPS of $-0.16.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is SRTS's fundamental grade?
Based on our AI fundamental analysis in June 2026, Sensus Healthcare, Inc. has a D grade with 88% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is SRTS stock overvalued or undervalued?
Valuation metrics for SRTS: ROE of -5.8% (sector avg: 15%), net margin of -77.4% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is SRTS's AI grade for 2026?
Our dual AI analysis gives Sensus Healthcare, Inc. a combined D grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is SRTS's free cash flow?
Sensus Healthcare, Inc.'s operating cash flow is $-3.8M, with capital expenditures of $3.0K. FCF margin is -110.7%.
How does SRTS compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -77.4% (avg: 12%), ROE -5.8% (avg: 15%), current ratio 7.27 (avg: 2).